MariMed Inc. Reports Q2 2026 Financial Results

What Happened

• MariMed Inc. (MRMD) filed a Form 8-K on August 12, 2026 to announce its financial results for the three- and six-month periods ended June 30, 2026. The company furnished a press release (Exhibit 99.1) reporting its quarterly results and incorporated that release by reference into the filing.

Key Details

• Filing date: August 12, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting periods: three- and six-month periods ended June 30, 2026.
• Exhibit included: Exhibit 99.1 — press release with the financial results; Exhibit 104 — Inline XBRL cover page data.
• The Form 8-K furnishes the press release (information incorporated by reference); detailed financial metrics are in the attached press release.

Why It Matters

• Quarterly earnings disclosures are material for investors evaluating revenue, profitability, and near-term performance trends. Reviewing the attached press release (Exhibit 99.1) will provide the specific revenue, earnings, cash flow, and other metrics needed to assess MariMed’s recent operating results. Investors should read the release and any subsequent SEC filings (e.g., 10-Q) for full financial details and context.